144 related articles for article (PubMed ID: 8045817)
61. Effects of angiotensin II on isolated rabbit afferent arterioles.
Yoshida H; Tamaki T; Aki Y; Kimura S; Takenaka I; Abe Y
Jpn J Pharmacol; 1994 Dec; 66(4):457-64. PubMed ID: 7723223
[TBL] [Abstract][Full Text] [Related]
62. Losartan, a specific angiotensin II receptor antagonist, increases angiotensin I and angiotensin II release from isolated rat hind legs: evidence for locally regulated renin-angiotensin system in vascular tissue.
Mizuno K; Tani M; Niimura S; Sanada H; Haga H; Hashimoto S; Watanabe H; Ohtsuki M; Fukuchi S
Life Sci; 1992; 50(23):PL209-14. PubMed ID: 1598061
[TBL] [Abstract][Full Text] [Related]
63. Analysis of angiotensins I, II, and III in pulmonary vascular bed of the rat.
Nossaman BD; Feng CJ; Wang J; Kadowitz PJ
Am J Physiol; 1994 Apr; 266(4 Pt 1):L389-96. PubMed ID: 8179016
[TBL] [Abstract][Full Text] [Related]
64. Mechanisms of impaired vascular response to ANG II in perivascular injured carotid arteries of ovariectomized rat.
Fukada SY; Iyomasa MM; Cunha FQ; Corrêa FM; de Oliveira AM
J Cardiovasc Pharmacol; 2004 Sep; 44(3):393-400. PubMed ID: 15475839
[TBL] [Abstract][Full Text] [Related]
65. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
66. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation.
Seyedi N; Xu X; Nasjletti A; Hintze TH
Hypertension; 1995 Jul; 26(1):164-70. PubMed ID: 7607720
[TBL] [Abstract][Full Text] [Related]
67. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.
Tamarat R; Silvestre JS; Durie M; Levy BI
Lab Invest; 2002 Jun; 82(6):747-56. PubMed ID: 12065685
[TBL] [Abstract][Full Text] [Related]
68. Binding characteristics and vascular effects of various angiotensin II antagonists.
Criscione L; Thomann H; Whitebread S; de Gasparo M; Bühlmayer P; Herold P; Ostermayer F; Kamber B
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S56-9. PubMed ID: 1705629
[TBL] [Abstract][Full Text] [Related]
69. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy.
Natarajan R; Gonzales N; Lanting L; Nadler J
Hypertension; 1994 Jan; 23(1 Suppl):I142-7. PubMed ID: 8282345
[TBL] [Abstract][Full Text] [Related]
70. Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II.
Roks AJ; Nijholt J; van Buiten A; van Gilst WH; de Zeeuw D; Henning RH
J Hypertens; 2004 Dec; 22(12):2355-61. PubMed ID: 15614030
[TBL] [Abstract][Full Text] [Related]
71. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors.
Morrell NW; Upton PD; Kotecha S; Huntley A; Yacoub MH; Polak JM; Wharton J
Am J Physiol; 1999 Sep; 277(3):L440-8. PubMed ID: 10484450
[TBL] [Abstract][Full Text] [Related]
72. Pharmacological characterization of angiotensin II binding sites in the canine pancreas.
Chappell MC; Diz DI; Jacobsen DW
Peptides; 1992; 13(2):313-8. PubMed ID: 1409010
[TBL] [Abstract][Full Text] [Related]
73. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.
Brosnihan KB; Li P; Ferrario CM
Hypertension; 1996 Mar; 27(3 Pt 2):523-8. PubMed ID: 8613197
[TBL] [Abstract][Full Text] [Related]
74. Angiotensin dependence of endothelium-mediated renal hemodynamics.
Sigmon DH; Carretero OA; Beierwaltes WH
Hypertension; 1992 Nov; 20(5):643-50. PubMed ID: 1330922
[TBL] [Abstract][Full Text] [Related]
75. Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms.
Touyz RM; Mercure C; Reudelhuber TL
J Biol Chem; 2001 Apr; 276(17):13657-63. PubMed ID: 11278387
[TBL] [Abstract][Full Text] [Related]
76. Effect of angiotensin II antagonism on canine renal sympathetic nerve function.
Wong PC; Hart SD; Timmermans PB
Hypertension; 1991 Jun; 17(6 Pt 2):1127-34. PubMed ID: 2045159
[TBL] [Abstract][Full Text] [Related]
77. Angiotensin-(1-7)-dependent vasorelaxation of the renal artery exhibits unique angiotensin and bradykinin receptor selectivity.
Yousif MHM; Benter IF; Diz DI; Chappell MC
Peptides; 2017 Apr; 90():10-16. PubMed ID: 28192151
[TBL] [Abstract][Full Text] [Related]
78. Effects of des-Asp-angiotensin I on the electrically stimulated contraction of the rabbit pulmonary artery.
Sim MK; Soh KS
Eur J Pharmacol; 1995 Sep; 284(1-2):215-9. PubMed ID: 8549630
[TBL] [Abstract][Full Text] [Related]
79. Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation.
Neuss M; Regitz-Zagrosek V; Hildebrandt A; Fleck E
Biochem Biophys Res Commun; 1994 Nov; 204(3):1334-9. PubMed ID: 7980612
[TBL] [Abstract][Full Text] [Related]
80. ANG II modifies cardiomyocyte function via extracardiac and intracardiac neurons: in situ and in vitro studies.
Horackova M; Armour JA
Am J Physiol; 1997 Mar; 272(3 Pt 2):R766-75. PubMed ID: 9087638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
